Drug repurposing strategy: An emerging approach to identify potential therapeutics for treatment of bovine mastitis

• DOI: 10.1016/j.micpath.2022.105691
• Publication Date: 2022-08-19T15:42:22Z
• Authors: Iqra Muzammil; Muhammad Ijaz; Muhammad Hassan S...; Muhammad Muddassi...
• Keywords: Methicillin-Resistant Staphylococcus aureus; 0301 basic medicine; Ivermectin; Anti-Inflammatory Agents, Non-Steroidal; Drug Repositioning; Amoxicillin; Bilirubin; Oxytetracycline; Microbial Sensitivity Tests; Staphylococcal Infections; Meloxicam; Anti-Bacterial Agents; 3. Good health; Cefoxitin; 03 medical and health sciences; Ciprofloxacin; Ketoprofen; Animals; Cattle; Female; Rabbits; Gentamicins; Mastitis, Bovine

The current study was designed to characterize methicillin-resistant Staphylococcus aureus (MRSA) isolated from bovine milk, along with its response to antibiotics, and ultimately reverse its mechanism of resistance by modulation with non-antibiotics. The synergistic combination of antibiotics with NSAIDs were tested in-vivo by giving MRSA challenge to rabbits. The current study reported an overall 23.79% prevalence of MRSA. The BLAST alignment of current study sequences revealed 99% similarity with mecA gene of MRSA from NCBI database. The current study isolates were more similar to each other and also with reference sequences as compared to other mecA gene sequences from Turkey, India, and Russia. Antibiogram of MRSA isolates showed a highly resistant response to cefoxitin, amoxicillin, and gentamicin. Amoxicillin, gentamicin, tylosin, vancomycin, and ciprofloxacin elicited a significant response (p < 0.05) in combination with non-antibiotics against tested MRSA isolates. The highest zone of inhibition (ZOI) increase was noted for vancomycin in combination with flunixin meglumine (145.45%) and meloxicam (139.36%); gentamicin with flunixin meglumine (85.71%) and ciprofloxacin with ivermectin (71.13%). Synergistic behavior was observed in the combination of gentamicin with ketoprofen; sulfamethoxazole and oxytetracycline with meloxicam. Hematological analysis showed significant differences (p < 0.05) among lymphocyte count and bilirubin. On histopathological examination of skin tissue, hyperplasia of epithelium, sloughed off epidermis, hyperkeratosis, infiltration of inflammatory cells, and hemorrhages were observed. The highest cure rate was observed in case of gentamicin in combination with ketoprofen as compared to other treatment groups. The current study concluded antibiotics in combination with non-antibiotics as potential therapeutic agents for resistance modulation against MRSA. This study will help to devise treatment and control strategies against bovine mastitis. Although the prospect of using NSAIDs to manage infections caused by MRSA appears to be a promising direction, further studies should be conducted to test these medications using suitable in-vivo models in controlled clinical trials to justify their repurposing as a treatment for MRSA infections.